Related Experiment Videos
Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease
Insights
Fecal alpha 1-antitrypsin (A1AT) levels can indicate protein-losing enteropathy in pediatric Crohn's disease. Elevated fecal A1AT strongly correlates with active disease, serving as a reliable, objective marker of intestinal damage.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Biomarker Discovery
Background:
- Crohn's disease (CD) is a chronic inflammatory bowel disease affecting children.
- Assessing disease activity in pediatric CD is crucial for effective management.
- Protein-losing enteropathy (PLE) is a complication associated with active CD.
Purpose of the Study:
- To evaluate fecal alpha 1-antitrypsin (A1AT) excretion as a noninvasive marker for disease activity in pediatric Crohn's disease.
- To correlate fecal A1AT levels with clinical disease activity and other scoring methods.
- To assess the utility of fecal A1AT as an objective indicator of intestinal damage in pediatric CD.
Main Methods:
- Fecal A1AT levels were measured in pediatric patients with Crohn's disease.
- Clinical disease activity was assessed using a composite score of 11 clinical parameters and subjective ratings.
- Retrospective correlation analysis was performed between fecal A1AT levels and various disease activity indices.
Main Results:
- Ninety-six percent of clinically active CD episodes showed elevated fecal A1AT levels (p < 0.001).
- Fecal A1AT elevation did not directly correlate with disease severity or location.
- A strong linear relationship (r = 0.93) was observed between fecal A1AT and intestinal A1AT clearance.
- Fecal A1AT demonstrated high correlation with subjective clinical ratings and devised activity scoring methods (r = 0.89-0.93).
Conclusions:
- Fecal A1AT excretion is a valuable, objective indicator for assessing Crohn's disease activity in children.
- This noninvasive marker can help identify the presence or absence of active intestinal inflammation.
- Simple subjective clinical ratings appear as effective as more complex scoring methods for evaluating disease activity.
Abstract:
Fecal alpha 1-antitrypsin excretion, a noninvasive indicator of protein-losing enteropathy, was correlated with clinical disease activity in pediatric patients with Crohn's disease. Disease activity was defined as the sum of 11 abnormal clinical parameters which were adapted from previously published disease activity scoring methods. Each patient was also given a subjective clinical rating when evaluated. In addition, four different devised disease activity scoring methods were correlated retrospectively with subjective clinical ratings for hospitalized patients. A total of 125 random fecal alpha 1-antitrypsin determinations were performed on 22 patients. Ninety-six percent of clinically active episodes of Crohn's disease were associated with elevated fetal alpha 1-antitrypsin (p less than 0.001). The degree of elevation was found not to correlate directly with the severity of assessed disease activity or site of intestinal involvement. A direct linear relationship was demonstrated between 23 paired random fecal alpha 1-antitrypsin and intestinal alpha 1-antitrypsin clearance assays (r = 0.93). There was a high, and remarkably similar, degree of correlation with each of the four different derived activity scoring methods and simple subjective ratings (r = 0.89-0.93). We conclude that: (a) fecal alpha 1-antitrypsin excretion may be helpful in assessing the presence or absence of Crohn's disease activity by providing an objective and specific indicator of intestinal damage; and (b) it appears that a simple subjective rating score is as clinically useful as other previously devised activity indices.